Agricultural Biologicals Market to Reach $43.53 Billion by 2035 at 10.1% CAGR | Syngenta AG, Bayer AG, BASF SE Among Key Players

The global agricultural biologicals market, valued at USD 16.62 billion in 2025, will reach USD 18.27 billion in 2026 and climb to USD 43.53 billion by 2035, advancing at a compound annual growth rate of 10.1% over the forecast period. Surging consumer demand for organic food, tightening government restrictions on synthetic chemicals, and rapid corporate investment in bio-based crop solutions are all accelerating adoption of biopesticides, biofertilizers, and biostimulants across every major agricultural region.

To explore the complete findings, request a free sample of the report at https://www.rootsanalysis.com/reports/agricultural-biologicals-market/request-sample.html

Market Overview
Agricultural biologicals encompass biopesticides, biofertilizers, and biostimulants derived from naturally occurring microorganisms, plant extracts, beneficial insects, and other organic matter. These products enhance soil fertility, stimulate plant growth, and reduce dependence on chemical inputs that have accumulated in soils for decades, degrading beneficial microbial populations and compromising crop health globally.

The urgency of the transition is no longer theoretical. Years of intensive chemical use have left widespread soil degradation across major growing regions, and regulatory bodies from Brussels to Tokyo are now mandating reductions in synthetic pesticide and fertilizer applications. The European Union's Farm to Fork strategy, adopted in 2020, set a target of cutting chemical pesticide use by 50%. Japan's Ministry of Agriculture, Forestry and Fisheries launched the Green Food System Strategy in August 2021, actively promoting biostimulant and biopesticide uptake. These policies are creating compliance-driven demand that runs parallel to the organic food market's own consumer-led momentum.

Corporate deal-making further signals the sector's maturity. More than 70% of the partnerships forged among agricultural biologicals companies have been inked since 2021, spanning distribution agreements, co-development contracts, and acquisitions. In January 2026, BASF Agricultural Solutions acquired AgBiTech Group from Paine Schwartz Partners to expand its biological insect control offerings. ICL completed the acquisition of Lavie Bio in August 2025, integrating the company's MicroBoost AI platform to accelerate microbial product discovery using machine learning. Corteva, through its Catalyst platform, invested in Symbiomics in June 2025 to deploy genomics-driven microbe discovery for enhanced crop yields.

Key Growth Drivers
Organic Food Demand Outpacing Conventional Supply Consumer preference for residue-free, certified organic produce is sustaining multi-year price premiums that make the economics of biological inputs compelling for growers. As global population growth increases food security pressure, biological crop solutions offer both a compliance path and a yield-support mechanism that chemical-only systems increasingly cannot deliver.

Regulatory Phase-Out of Synthetic Chemicals EU directives, Japanese agricultural reform, and similar initiatives across North America are setting binding reduction targets for synthetic pesticide and fertilizer use. This regulatory pressure is converting agricultural biologicals from an optional premium product into a necessary component of any compliant crop protection program.
Accelerating Industry R&D and Patent Activity More than 1,300 patents related to agricultural biologicals have been filed since 2019, with approximately 75% filed as applications for novel biologic crop solutions. PI Industries, BASF SE, and Monsanto lead by patent volume. This pace of intellectual property creation reflects genuine scientific progress and signals that biological crop protection products are moving from early-stage trials toward commercial-scale deployment.

Strategic M&A and Distribution Partnerships Key players are actively acquiring capabilities and expanding geographic reach. Syngenta AG signed a distribution agreement with Unium Bioscience in May 2023 for biostimulants across Northwest Europe. Bayer AG and Kimitec partnered in February 2023 to develop and commercialize biopesticides and biostimulants, and followed that up in June 2025 with the joint launch of next-generation Ambition Complete Gen2 and Secure Gen2 biological products. In January 2024, UPL acquired Corteva Agriscience's fungicide business to extend its biological crop protection portfolio. These deals are accelerating time-to-market and widening distribution networks faster than organic growth alone could achieve.

AI and Genomics Integration Shortening Development Cycles The application of machine learning to microbial discovery, exemplified by ICL's integration of Lavie Bio's MicroBoost AI platform, and the use of genomics platforms like Symbiomics to identify yield-enhancing microbes, is compressing product development timelines. These technologies address one of the sector's historically cited limitations: inconsistent field performance across varied soil and climate conditions.

Market Segmentation
By product type, biopesticides currently hold the largest share of the agricultural biologicals market and are expected to maintain that position through 2035, benefiting from the most direct substitution pathway for farmers transitioning away from synthetic crop protection chemicals. Biofertilizers and biostimulants represent fast-growing complementary segments, with biostimulants attracting particularly strong partnership activity at the distribution level.

By mode of application, foliar sprays account for close to 55% of the current market, reflecting their compatibility with existing farm equipment and established agronomic practice. Seed treatments and soil treatments are growing segments, particularly as precision agriculture and microbiome management practices expand. By source, microbial products capture the dominant share and are expected to sustain leadership given their broad-spectrum activity and the depth of the patent pipeline supporting them. By crop type, cereals and pulses, fruits and nuts, and vegetables and tubers represent the primary addressable categories.

To request quote of this report, please visit:
https://www.rootsanalysis.com/reports/agricultural-biologicals-market/request-quote.html

Regional Insights
North America and Europe collectively account for approximately 60% of the global agricultural biologicals market today, anchored by strong organic food consumer bases, advanced distribution infrastructure, and the most mature regulatory frameworks mandating the shift away from synthetic chemicals. North American demand has expanded rapidly in recent years, driven by farmer adoption of biological inputs as organic acreage expands across the United States and Canada.

Asia Pacific will grow at the highest CAGR among all regions through 2035, fueled by its large agricultural base, rising middle-class demand for food safety and organic certification, and government programs in Japan and other markets explicitly directing farmers toward biological inputs. Notably, approximately 40% of global agricultural biologicals manufacturers are already headquartered in Asia Pacific, with India and China functioning as primary production hubs, positioning the region to benefit from both supply-side scale and domestic demand expansion.

Latin America is also gaining pace. US-based DPH Biologicals recently announced plans to launch three new agricultural biological products in the Latin American market, and the region's large-scale row crop production footprint makes it a natural fit for biopesticide and biofertilizer adoption at scale.

Competitive Landscape
The agricultural biologicals industry features more than 200 companies operating across the full spectrum from very small startups to multinational corporations. Key players profiled in the Roots Analysis report include AMVAC, Andermatt, BASF SE, Bayer AG, Certis Biologicals, Chr. Hansen, Corteva Agriscience, FBSciences, Koppert Biological Systems, Lallemand, Marrone Bio Innovations, Novozymes, Stoller, Syngenta AG, UPL, Valent Biosciences, Vegalab, and Verdisian Life Sciences, among others.

The market remains well-fragmented, with no single player commanding a dominant share. Competition centers on product portfolio breadth, geographic distribution reach, and the ability to demonstrate consistent field performance across diverse crop and climate conditions. The major agrochemical companies (Syngenta, Bayer, BASF, Corteva) are using acquisitions and partnerships to bolt on biological capabilities alongside their conventional chemistry businesses, while specialist biologicals firms compete on scientific depth and speed of regulatory approval. More than 35% of companies now offer all three product categories (biopesticides, biofertilizers, and biostimulants), reflecting market pressure to provide integrated biological crop management programs rather than single-product solutions.

Browse Full Report Description + Research Methodology + Table of Content + Infographics here:
https://www.rootsanalysis.com/reports/agricultural-biologicals-market.html

Contact Details
Gaurav Chaudhary
Email: Gaurav.chaudhary@rootsanalysis.com or sales@rootsanalysis.com
Website: https://www.rootsanalysis.com

About Roots Analysis
Roots Analysis is a global leader in the pharma / biotech market research. Having worked with over 750 clients worldwide, including Fortune 500 companies, start-ups, academia, venture capitalists and strategic investors for more than a decade, we offer a highly analytical / data-driven perspective to a network of over 450,000 senior industry stakeholders looking for credible market insights. All reports provided by us are structured in a way that enables the reader to develop a thorough perspective on the given subject. Apart from writing reports on identified areas, we provide bespoke research / consulting services dedicated to serve our clients in the best possible way.

This release was published on openPR.